The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
most notably Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center. The CDD bridges the gap between academic research and pharmaceutical discovery and provides researchers ...
In a statement, Dr. Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and Research, called the approval “an important public health milestone in acute pain ...